QR-koodi

EGFR-targeted photoimmunotherapy and its association with the immune microenvironment in locoregional recurrent head and neck squamous cell carcinoma

BackgroundEpidermal growth factor receptor (EGFR)-targeted photoimmunotherapy using cetuximab sarotalocan sodium (RM-1929) represents a novel therapeutic modality that induces selective tumor cell death and may influence the tumor immune microenvironment (TIME) in head and neck squamous cell carcino...

Täydet tiedot

Tallennettuna:
Päätekijät: Koichi Yoshizawa, Takahiro Tsujikawa, Peesit Leelasawatsuk, Mai Mohamed Bedeir, Yuna van der Aar, Tim de Martines, Saya Shibata, Hiroshi Ogi, Ryuhei Okada, Alisa Kimura, Hiroki Morimoto, Sumiyo Saburi, Shigeyuki Mukudai, Hikaru Nagao, Aya Miyagawa-Hayashino, Eiichi Konishi, Kyoko Itoh, Takahiro Asakage, Shigeru Hirano
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2026-04-01
Sarja:Frontiers in Immunology
Aiheet:
EGFR
head and neck squamous cell carcinoma
immune microenvironment
locoregional recurrence
photoimmunotherapy
Linkit:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1814205/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia